Skip to main content

Advertisement

Log in

Prognostic value of non-alcoholic fatty liver disease in the elderly patients

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background

Non-alcoholic fatty liver disease (NAFLD) is the liver manifestation of metabolic syndrome, a risk factor for mortality and cardiovascular morbidity, but we ignore the role of steatosis per se in survival, and there is very little information about this condition in the geriatric patient.

Aims

With the present study, we investigated the independent prognostic value of NAFLD on overall mortality in the elderly.

Methods

Within the Pianoro Project, involving people ≥ 65 years, anamnestic, clinical and laboratoristic data related to NAFLD, insulin resistance, diabetes/hyperglycemia, hypertension, obesity and dyslipidemia were collected in 804 subjects (403 male, 401 female). These subjects were followed up for mortality for a median time of 12.6 years. A multivariate analysis was performed to evaluate the prognostic value of the covariates.

Results

At Kaplan–Meier estimator the presence of NAFLD seems to be associated to a lower mortality, and survival tends to increase with the increasing of steatosis grade. Cox’s analysis found that survival is increased for subjects having hypercholesterolemia (RR = 0.565), NAFLD (RR = 0.777), hypertension (RR = 0.711) and in female (RR = 0.741), while it is decreased for the older subjects (RR = 3.046), in patients with hypertriglyceridemia (RR = 1.699) and for diabetics (RR = 1.797). The variables BMI and HDL-cholesterol have no role.

Conclusion

The data obtained in our study show that NAFLD is not associated to overall mortality in the elderly population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Marchesini G, Day CP, Dufour JF et al (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. https://doi.org/10.1016/j.jhep.2015.11.004

    Article  PubMed  Google Scholar 

  2. McCullough AJ (2006) Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol. https://doi.org/10.1097/01.mcg.0000168645.86658.22

    Article  PubMed  Google Scholar 

  3. Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Pharmacol Ther Aliment. https://doi.org/10.1111/j.1365-2036.2011.04724.x

    Article  Google Scholar 

  4. Neuschwander-Tetri BA (2005) Nonalcoholic steatohepatitis and the metabolic syndrome. BMC Med. https://doi.org/10.1186/s12916-017-0806-8

    Article  Google Scholar 

  5. Adams LA, Angulo P (2005) Recent concepts in non-alcoholic fatty liver disease. Med Diabet. https://doi.org/10.1111/j.1464-5491.2005.01748.x

    Article  Google Scholar 

  6. Marchesini G, Bugianesi E, Forlani G et al (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. https://doi.org/10.1053/jhep.2003.50161

    Article  PubMed  Google Scholar 

  7. Lonardo A, Ballestri S, Marchesini G et al (2015) Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. https://doi.org/10.1016/j.dld.2014.09.020

    Article  PubMed  Google Scholar 

  8. Frith J, Day CP, Robinson L et al (2010) Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. J Hepatol. https://doi.org/10.1016/j.jhep.2009.10.010

    Article  PubMed  Google Scholar 

  9. Hong HC, Hwang SY, Choi HY et al (2014) Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study. Hepatology. https://doi.org/10.1002/hep.26716

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kitajima Y, Eguchi Y, Ishibashi E et al (2010) Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. J Gastroenterol. https://doi.org/10.1007/s00535-009-0147-2

    Article  PubMed  Google Scholar 

  11. Franceschi C, Campisi J (2014) Chronic inflammation (Inflammaging) and its potential contribution to age-associated diseases. Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glu057

    Article  Google Scholar 

  12. Beyer I, Mets T, Bautmans I (2012) Chronic low-grade inflammation and age-related sarcopenia. Opin Clin Nutr Metab Care Curr. https://doi.org/10.1097/MCO.0b013e32834dd297

    Article  Google Scholar 

  13. Bertolotti M, Lonardo A, Mussi C et al (2014) Nonalcoholic fatty liver disease and aging: epidemiology to management. Gastroenterol World J. https://doi.org/10.3748/wjg.v20.i39.14185

    Article  Google Scholar 

  14. Brea A, Mosquera D, Martín E et al (2005) Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol. https://doi.org/10.1161/01.ATV.0000160613.57985.18

    Article  PubMed  Google Scholar 

  15. Abbatecola AM, Ferrucci L, Marfella R, Paolisso G (2007) Insulin resistance and cognitive decline may be common soil for frailty syndrome. Intern Med Arch. https://doi.org/10.1001/archinte.167.19.2145-b

    Article  Google Scholar 

  16. Pi-Sunyer FX, Becker DM, Bouchard C et al (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr. https://doi.org/10.1093/ajcn/68.4.899

    Article  Google Scholar 

  17. Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care. https://doi.org/10.2337/diacare.20.7.1087

    Article  PubMed  Google Scholar 

  18. Bugianesi E, Gastaldelli A, Vanni E et al (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. https://doi.org/10.1007/s00125-005-1682-x

    Article  PubMed  Google Scholar 

  19. Bugianesi E, Pagotto U, Manini R et al (2005) Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2004-2240

    Article  PubMed  Google Scholar 

  20. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. https://doi.org/10.1016/0021-9681(87)90171-8

    Article  PubMed  Google Scholar 

  21. Siri WE (1993) Body composition from fluid spaces and density: analysis of methods. 1961. Nutrition 9:480–491

    CAS  PubMed  Google Scholar 

  22. Ekstedt M, Franzén LE, Mathiesen UL et al (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. https://doi.org/10.1002/hep.21327

    Article  PubMed  Google Scholar 

  23. Zeb I, Li D, Budoff MJ et al (2016) Nonalcoholic fatty liver disease and incident cardiac events the multi-ethnic study of atherosclerosis. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2016.01.07

    Article  PubMed  Google Scholar 

  24. Agricola E, Bove T, Oppizzi M et al (2005) “Ultrasound comet-tail images”: a marker of pulmonary edema: a comparative study with wedge pressure and extravascular lung water. Chest 127:1690–1695. https://doi.org/10.1378/chest.127.5.1690

    Article  PubMed  Google Scholar 

  25. Bedogni G, Miglioli L, Masutti F et al (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study. Hepatology. https://doi.org/10.1002/hep.20734

    Article  PubMed  Google Scholar 

  26. Kagansky N, Levy S, Keter D et al (2004) Non-alcoholic fatty liver disease—a common and benign finding in octogenarian patients. Liver Int. https://doi.org/10.1111/j.1478-3231.2004.0969.x

    Article  PubMed  Google Scholar 

  27. Koehler EM, Schouten JNL, Hansen BE et al (2012) Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol. https://doi.org/10.1016/j.jhep.2012.07.028

    Article  PubMed  Google Scholar 

  28. Bangalore S, Gong Y, Cooper-Dehoff RM et al (2014) 2014 eighth joint national committee panel recommendation for blood pressure targets revisited: results from the invest study. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2014.05.044

    Article  PubMed  PubMed Central  Google Scholar 

  29. Schatz IJ, Masaki K, Yano K et al (2001) Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet. https://doi.org/10.1016/S0140-6736(01)05553-2

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guerino Recinella.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Statement of human and animal rights

All procedures and the research protocol have been approved by the locally appointed ethics committee of the University of Bologna. The experimental protocol was designed in accordance with the Declaration of Helsinki (1964).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tallarico, V., Recinella, G., Magalotti, D. et al. Prognostic value of non-alcoholic fatty liver disease in the elderly patients. Aging Clin Exp Res 32, 2657–2665 (2020). https://doi.org/10.1007/s40520-020-01487-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-020-01487-2

Keywords

Navigation